To compare the post-prandial muscle protein synthetic response following ingestion of a whole-food meal containing meat versus the ingestion of a meal containing only plant-based protein sources in vivo in healthy, older men and women.
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
This study will evaluate the skeletal muscle anabolic response following the ingestion of a protein rich meal
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary endpoint will be mixed muscle protein synthesis rates over the full
6h post-prandial period following meal ingestion.
Secondary outcome
Plasma glucose, insulin and amino acid concentrations, as well as breath
13C/12C ratio following meal ingestion.
Background summary
Food intake stimulates muscle protein synthesis rates. The magnitude of the
anabolic response to feeding forms a key factor in regulating muscle mass
maintenance. Ingestion of animal-derived proteins generally leads to a greater
stimulation of muscle protein synthesis when compared to the ingestion of
plant-derived proteins. What is often neglected is that the anabolic properties
of protein isolates do not necessarily reflect the anabolic response to the
ingestion of the whole-foods from which they are derived. This discrepancy is
due to the presence or absence of other components normally found within
whole-food matrices, which influence protein digestion and amino acid
absorption from animal based and plant based protein sources. A rapid and
robust post-prandial release of food-derived amino acids is of particular
relevance for older individuals, who typically show a blunted muscle protein
synthetic response to feeding
Study objective
To compare the post-prandial muscle protein synthetic response following
ingestion of a whole-food meal containing meat versus the ingestion of a meal
containing only plant-based protein sources in vivo in healthy, older men and
women.
Study design
randomized, counter-balanced, cross-over design, researchers and participants
are not blinded, analysts are blinded.
Intervention
Participants will undergo 2 test days. On one test day participants will
consume a meal containing meat, the other day participants will consume a meal
without meat.
Study burden and risks
The burden and risks involved in participating in this experiment are small.
Participants will visit the University on three occasions (screening + 2 test
days). The first visit will involve a screening visit (~2 h), during which the
eligibility of the participant will be assessed. During the screening visit, a
medical questionnaire is filled out, and a DEXA scan will be performed to
assess body composition, where the level of radiation is very low compared to
the background radiation level in the Netherlands.
The participants will participate in 2 test days of ~12h. Insertion of the
catheters during the test days is comparable to a normal blood draw and the
only risk is a small local hematoma. During each of the 2 experimental test
days 16 blood samples (170mL/day) will be obtained. The total amount of blood
collected during this study is less than the amount of a blood donation and
will be completely restored in approximately 1 month. The stable isotope amino
acids tracers that will be infused intravenously during the experimental trial
are produced according to GMP standards and are safe for human use. Throughout
each test day, muscle biopsies will be obtained under local anaesthesia by an
experienced physician, but may cause some minor discomfort. The discomfort is
comparable to muscle soreness or the pain one has after bumping into the corner
of a table. Additional expired breath samples will be collected and analysed
for 13C/12C ratio, this procedure is comparable to gently exhaling in a balloon
and does not involve any risks.
For each visit participants are required to come to the university in a fasted
state, not having consumed any food or beverages (except for water) as from
22:00 the evening before. Also, 2 days prior to the experimental test days
participants need to record their food intake and activities performed. During
these 2 days participants are not allowed to perform heavy physical exercise or
drink alcohol. There is no direct benefit for the participants, except from
their contribution to scientific knowledge on the impact of whole food protein
ingestion on stimulation of muscle protein synthesis.
Universiteitssingel 50
Maastricht 6229 ER
NL
Universiteitssingel 50
Maastricht 6229 ER
NL
Listed location countries
Age
Inclusion criteria
- Aged 65-85 years
- Body mass index 18.5 * 30 kg/m2
- Healthy
- Having given informed consent
Exclusion criteria
- Allergy for one of the food items used
- >5% weight change in the previous 6 months
- Blood pressure >140/90 mmHg
- Participating in a structured (progressive) exercise program
- Smoking
- Diagnosed musculoskeletal disorders
- Diagnosed metabolic disorders (e.g. diabetes)
- Use of any medications known to affect protein metabolism (i.e.
corticosteroids, non-steroidal anti-inflammatories).
- Chronic use of gastric acid suppressing medication
- Chronic use of anti-coagulants
- Recent (<1 year) participation in amino acid tracer
(L-[ring-13C6]-phenylalanine and L-[3,5-2H2]-tyrosine studies
- Diagnosed GI tract disorders or diseases
- Blood donation in the past 2 months
- Strict vegan diet
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL76626.068.21 |
Other | Protocol will be registered at ClinicalTrials.gov after approval by the METC |